Clinical Trial Information
Phase II Study of Cabozantinib in Combination with Nivolumab and Ipilimumab in Rare Genitourinary Tumors
- Protocol Number: A031702
- Status: Open
- Age Group: Adult
- Treatment Type: Treatment
- Phase: II
- NCT ID: NCT03866382
Scope Information
- Scope:
- National
- Disease Site(s):
- Kidney, Other Urinary, Prostate, Urinary Bladder
